-
$2,000 Read More Diabetic Peripheral Neuropathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete wit... -
$2,000 Read More Mumps – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2016’, provides an overview of the Mumps pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target, mechanism of action (MoA),... -
$2,000 Read More Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Elephantiasis (Lymphatic Filaria... -
$2,000 Read More Streptococcus pyogenes Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Streptococcus pyogenes Infections - Pipeline Review, H1 2016’, provides an overview of the Streptococcus pyogenes Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections, com... -
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2016’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More H3N2 Infection – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for H3N2 Infection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological a... -
$2,000 Read More Allergic Asthma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological ... -
$2,000 Read More Metastatic Renal Cell Carcinoma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Renal Cell Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ... -
$2,000 Read More Atopic Dermatitis – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Atopic dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologica... -
$2,000 Read More Traumatic Brain Injury – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Traumatic brain injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacol...
Sorry, there is no ad related to this category!
-
$4,995 Read More Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 – In...
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia – high blood […]
-
$2,000 Read More Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Revie...
Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2016’, provides […]
-
$2,000 Read More Nasopharyngitis (Common Cold) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016’, provides an overview of […]
-
$4,700 Read More Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinedione...
Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of […]
-
$4,995 Read More Prostate Cancer Market to 2021 – Increasing Disease Prevalence to be a Key...
Prostate Cancer (PC) is a disease predominately of the elderly with 60% of cases diagnosed […]
-
$2,000 Read More Duchenne Muscular Dystrophy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Duchenne Muscular Dystrophy – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Dilated Cardiomyopathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Dilated Cardiomyopathy – Pipeline Review, H1 2016’, provides an overview of the […]
-
Read More Diabetic Neuropathic Pain – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Neuropathic Pain – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Epilepsy – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis […]